Invega Sustenna Sales Data
| Rank 78 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Invega Sustenna U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 78 ( 11) |
$214,251 | 10.03% | 170 | 9.68% |
| Q3 2013 | 89 (1) |
$194,724 | 5.47% | 155 | n/a |
| Q2 2013 | 90 ( ) |
$184,629 | n/a | 155 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.